Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma
- Conditions
- Bronchial Asthma
- Interventions
- Other: Alternative nostril breathingDrug: Pharmacological therapy
- Registration Number
- NCT06609941
- Lead Sponsor
- Foundation University Islamabad
- Brief Summary
Bronchial asthma is a widespread chronic condition charactrized by inflammation and narrowing of airways, leading to repeateted episodes of breathlessness, wheezing and labored breathing.Breathing exercises help to manage hyperventilation often seen in asthmatic patients. To handle respiratory complications asthmatics are advised to practise nasal breathing techniques in conjunction with their prescribed medications.
- Detailed Description
Bronchial asthma is a very common chronic disease marked by inflammation and constriction of airways, resulting in recurrent episodes of breathlessness, wheezing and decrease work of breathing. Breathing exercises help to manage hyperventilation associated with asthma. In order to manage respiratory conditions asthmatic patients are encouraged for nasal breathing techniques along with pharmacological management. Hence the objective of the study is to compare the effects of alternative nostril breathing along with pharmacological management versus pharmacological management alone on dyspnea, control pause, asthma control and peak expiratory flow rate in patients with bronchial asthma.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 32
- Adults: aged (18-45 years)
- Gender: Both males and females
- Grade1- Grade 4 on Modified MRC dyspnea scale
- Asthma severity classes (intermediate, mild persistent and moderate persistent asthma) acc. to NAEPP national asthma education and prevention program guidlin
- Patients having acute exacerbation of COPD or status asthmaticus
- Patients diagnosed with acute infections
- Patients unable to follow command/ instructions
- Asthma patients with >40 sec control pause duration
- Patients who fall in red zone of asthma action plan (PEFR < 50%)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Nostril Breathing along with pharmacological therapy Group Alternative nostril breathing Patients in this group will receive alternative nostril breathing along with pharmacological management. Total 4 weeks protocol. Two sessions per week will be supervised by physiotherapist and 5 days at home. A home diary will be provided in order to ensure and follow-up that participants are performing breathing exercise at home. Nostril Breathing along with pharmacological therapy Group Pharmacological therapy Patients in this group will receive alternative nostril breathing along with pharmacological management. Total 4 weeks protocol. Two sessions per week will be supervised by physiotherapist and 5 days at home. A home diary will be provided in order to ensure and follow-up that participants are performing breathing exercise at home. Pharmacological therapy Group Pharmacological therapy Patients will receive medication as prescribed by pulmonologist through stepwise approach according to symptoms and severity. Total 4 weeks protocol. Before and after 4 weeks pre and post interventional values will be taken.
- Primary Outcome Measures
Name Time Method Dyspnea 4 weeks Evaluation will be done using Dyspnea-12 questionnaire for dyspnea
Control pause 4 weeks Stopwatch will be used to measure control pause.
Asthma control 4 weeks Asthma control test (ACT) will be used to evaluate asthma control and peak flow meter for peak expiratory flow rate.
Peak expiratory flow rate. 4 Weeks Peak flow meter will be used to measure peak expiratory flow rate
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Foundation University College of Physical Therapy
🇵🇰Rawalpindi, Punjab, Pakistan